Aditi Shastri, MD: Clinicians Need to ‘Come Together’ on TP53-Mutated MDS
The HemOnc Pulse
00:00
Observation vs Intervention in Patients with MDS
This chapter explores the decision-making process of observing patients with myelodisplasia (MDS) and discusses the potential benefits and risks of waiting versus intervening. It also highlights differing opinions within the MDS community and emphasizes the importance of patient selection and careful discussion.
Transcript
Play full episode
